Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Moderate Term Musculoskeletal Outcomes With Escalating Dose Prophylaxis: the Canadian Hemophilia Prophylaxis Study Follow-up Study

NCT01085344 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT01085344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01085344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Moderate Term Musculoskeletal Outcomes With Escalating Dose Prophylaxis: the Canadian Hemophilia Prophylaxis Study Follow-up Study
Lead sponsor
The Hospital for Sick Children
Phase
Phase 4
Overall status
Completed
Start date
June 26, 1997
Completion date
December 31, 2014
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe hemophilia a